Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China flag China · Delayed Price · Currency is CNY
14.27
+0.20 (1.42%)
Apr 8, 2026, 3:00 PM CST

SHA:600535 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,4362,9944,4513,1192,304
Short-Term Investments
1,404----
Trading Asset Securities
1,394524.72300.711,1251,487
Cash & Short-Term Investments
4,2343,5184,7514,2443,791
Cash Growth
20.34%-25.95%11.95%11.95%78.94%
Accounts Receivable
2,4181,9662,1313,3483,796
Other Receivables
39.9623.0611.498.989.47
Receivables
2,4581,9892,1423,3573,805
Inventory
1,4271,7121,7481,5321,548
Other Current Assets
111.591.7291.43127.08105
Total Current Assets
8,2307,3118,7339,2609,249
Property, Plant & Equipment
3,5463,6483,7693,8834,088
Long-Term Investments
1,3461,8212,0541,5111,229
Goodwill
--15.8815.88167.08
Other Intangible Assets
794.39604.17573.64459.43474.54
Long-Term Deferred Tax Assets
67.0553.175088.2960.79
Long-Term Deferred Charges
1,3331,4661,4761,1571,193
Other Long-Term Assets
22.6672.5443.14102.0879.68
Total Assets
15,34014,97616,71416,47716,542
Accounts Payable
376.9606.81572.73887.77728.58
Accrued Expenses
537.57171.05178.38242.79213.15
Short-Term Debt
1,116699.54814.63201.77188.79
Current Portion of Long-Term Debt
4.96586.83462.74475.21343.33
Current Portion of Leases
49.747.8458.5453.9855.67
Current Income Taxes Payable
110.9157.7818.0484.62108.09
Current Unearned Revenue
49.8869.8591.6292.3568.33
Other Current Liabilities
62.39109.98172.88108.72149.12
Total Current Liabilities
2,3082,3502,3702,1471,855
Long-Term Debt
216.87253.761,4141,3761,034
Long-Term Leases
51.1967.9781.5275.3181.63
Long-Term Unearned Revenue
189.95193.29159.02177.79214.57
Long-Term Deferred Tax Liabilities
26.020.40.1122.8742.18
Total Liabilities
2,7922,8654,0243,7993,228
Common Stock
1,4941,4941,5001,5001,513
Additional Paid-In Capital
482.39458.96958.081,4571,530
Retained Earnings
10,3919,8989,9299,35110,222
Treasury Stock
---105.98-105.98-251.29
Comprehensive Income & Other
37.2452.2288211.58-32.19
Total Common Equity
12,40411,90312,36812,41212,981
Minority Interest
143.49207.86321.59265.12332.56
Shareholders' Equity
12,54812,11112,69012,67813,314
Total Liabilities & Equity
15,34014,97616,71416,47716,542
Total Debt
1,4381,6562,8312,1821,704
Net Cash (Debt)
2,7951,8621,9202,0622,088
Net Cash Growth
50.10%-2.99%-6.89%-1.23%-
Net Cash Per Share
1.871.251.291.401.39
Filing Date Shares Outstanding
1,4941,4941,4941,4941,499
Total Common Shares Outstanding
1,4941,4941,4941,4941,499
Working Capital
5,9224,9616,3637,1137,394
Book Value Per Share
8.307.978.288.318.66
Tangible Book Value
11,61011,29911,77911,93712,340
Tangible Book Value Per Share
7.777.567.887.998.23
Buildings
3,5293,5173,5053,4903,398
Machinery
3,8033,7633,6253,4723,340
Construction In Progress
322.42221.76153.87102.96167.85
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.